Emerald Advisers, LLC Iveric Bio, Inc. Transaction History

Emerald Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$26.24 - $39.63 $1.42 Million - $2.14 Million	-53,986 Reduced 7.16%	700,046 $27.5 Million
Q1 2023 May 04, 2023	SELL	$18.67 - $24.56 $112,244 - $147,654	-6,012 Reduced 0.79%	754,032 $18.3 Million
Q4 2022 Feb 03, 2023	SELL	$17.24 - $23.95 $3.5 Million - $4.86 Million	-202,863 Reduced 21.07%	760,044 $16.3 Million
Q3 2022 Oct 25, 2022	BUY	$9.4 - $18.59 $9.05 Million - $17.9 Million	962,907 New	962,907 $17.3 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.